Pfizer, GSK To Have Imported Drugs Fast-Tracked By FDA

Law360, New York (February 18, 2014, 9:10 PM EST) -- Pfizer Inc. and GlaxoSmithKline LLC were among the 13 pharmaceutical titans whose imported drugs will receive expedited U.S. entry under a pilot program launched Tuesday that's designed to free up the U.S. Food and Drug Administration to pay more attention to less trustworthy foreign-made medicines.

The importation of up to five drugs made by each company that prequalified for the two-year Secure Supply Chain program will be fast-tracked, while the FDA shifts more of its surveillance resources toward products it said could pose a greater threat...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.